amitriptyline has been researched along with Bladder Disorder, Neurogenic in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, J | 1 |
| Sivaraman Nair, KP | 1 |
| Taly, AB | 1 |
| Murali, T | 1 |
| Jameson, RM | 1 |
2 other studies available for amitriptyline and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
Spontaneous expulsion of large vesicle calculi in a woman with paraparesis.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Female; Humans; India; Myelitis, Transverse; | 1999 |
Management of the bladder in non-traumatic paraplegia.
Topics: Amitriptyline; Female; Humans; Imipramine; Male; Multiple Sclerosis; Myelitis; Neoplasm Metastasis; | 1974 |